Marson is developing genome editing technologies to understand how sequence variation in the human genome alters and controls T cell immune function. He aims to engineer a new generation of targeted therapies for autoimmune disorders, immunodeficiencies, and infectious diseases.
BACK TO ALL
ALEX MARSON, M.D., PH.D.

Scientific Advisory Board
GET CZ BIOHUB UPDATES IN YOUR INBOX
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.